Plerixafor: A Review of its Use in Stem-Cell Mobilization in Patients with Lymphoma or Multiple Myeloma

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.12, 2011-08, pp. : 1623-1647

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plerixafor: In Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma

By Wagstaff Antona J.

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 319-326

Adis International

Access to resources Recommend Favorite

Bortezomib: A Review of its Use in Patients with Multiple Myeloma

By Curran Monique P. McKeage Kate

Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. : 859-888

Adis International

Access to resources Recommend Favorite

Bendamustine: A Review of its Use in the Management of Chronic Lymphocytic Leukaemia, Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma and Multiple Myeloma

By Hoy Sheridan M.

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1929-1950

Adis International

Access to resources Recommend Favorite

Lenograstim: A Review of its Use in Chemotherapy-Induced Neutropenia, for Acceleration of Neutrophil Recovery Following Haematopoietic Stem Cell Transplantation and in Peripheral Blood Stem Cell Mobilization

By Keating Gillian M.

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 679-707

Adis International

Access to resources Recommend Favorite

Stem Cell Transplantation in Multiple Myeloma

Current Cancer Drug Targets, Vol. 17, Iss. 9, 2017-10 ,pp. : 769-781

Bentham Science Publishers

Access to resources Recommend Favorite